Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania

P. Drevinek, R. Flisiak, R. Nemes, KA. Nogales Crespo, K. Tomasiewicz

. 2024 ; 14 (6) : . [pub] 20240316

Status not-indexed Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc24005572

Grant support
No grant number available. Abbott Laboratories

This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, Poland, and Romania. The paper was constructed based on a review of scientific evidence and national and international policies and recommendations, as well as a process of validation by four experts. The development of new testing technologies, treatment options, and increased awareness of the negative multidimensional impact of ARI profiles transformed differential diagnosis into a tangible and desirable reality. This review covers the following topics: (1) the multidimensional impact of ARIs, (2) ARI rapid diagnostic testing platforms and their value, (3) the policy landscape, (4) challenges and barriers to implementation, and (5) a set of recommendations illustrating a path forward. The findings indicate that rapid diagnostic testing, including at the point of care (POC), can have a positive impact on case management, antimicrobial and antibiotic stewardship, epidemiological surveillance, and decision making. Integrating this strategy will require the commitment of governments and the international and academic communities, especially as we identified room for improvement in the access and expansion of POC rapid testing in the focus countries and the inclusion of rapid testing in relevant policies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24005572
003      
CZ-PrNML
005      
20240412131001.0
007      
ta
008      
240405s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/diagnostics14060631 $2 doi
035    __
$a (PubMed)38535051
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Drevinek, Pavel $u Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic $u Czech Society for Medical Microbiology, Czech Medical Association of J.E. Purkyne, 142 20 Prague, Czech Republic $1 https://orcid.org/0000000289945240 $7 xx0075827
245    14
$a The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania / $c P. Drevinek, R. Flisiak, R. Nemes, KA. Nogales Crespo, K. Tomasiewicz
520    9_
$a This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, Poland, and Romania. The paper was constructed based on a review of scientific evidence and national and international policies and recommendations, as well as a process of validation by four experts. The development of new testing technologies, treatment options, and increased awareness of the negative multidimensional impact of ARI profiles transformed differential diagnosis into a tangible and desirable reality. This review covers the following topics: (1) the multidimensional impact of ARIs, (2) ARI rapid diagnostic testing platforms and their value, (3) the policy landscape, (4) challenges and barriers to implementation, and (5) a set of recommendations illustrating a path forward. The findings indicate that rapid diagnostic testing, including at the point of care (POC), can have a positive impact on case management, antimicrobial and antibiotic stewardship, epidemiological surveillance, and decision making. Integrating this strategy will require the commitment of governments and the international and academic communities, especially as we identified room for improvement in the access and expansion of POC rapid testing in the focus countries and the inclusion of rapid testing in relevant policies.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Flisiak, Robert $u Department of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Białystok, Poland $u Polish Association of Epidemiologists and Infectiologists, 15-540 Białystok, Poland $1 https://orcid.org/0000000333941635
700    1_
$a Nemes, Roxana $u Department of Preclinical Disciplines, Faculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania $u Romanian Society of Pneumonology, 050159 Bucharest, Romania $1 https://orcid.org/0000000198581162
700    1_
$a Nogales Crespo, Katya A $u Policy Wisdom LLC., Quebradillas 00678-2705, Puerto Rico $1 https://orcid.org/0000000158060805
700    1_
$a Tomasiewicz, Krzysztof $u Polish Association of Epidemiologists and Infectiologists, 15-540 Białystok, Poland $u Department and Clinic of Infectious Diseases and Hepatology SPSK-1, Medical University of Lublin, 20-081 Lublin, Poland
773    0_
$w MED00195450 $t Diagnostics $x 2075-4418 $g Roč. 14, č. 6 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38535051 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240412130953 $b ABA008
999    __
$a ok $b bmc $g 2075955 $s 1215334
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 14 $c 6 $e 20240316 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
GRA    __
$a No grant number available. $p Abbott Laboratories
LZP    __
$a Pubmed-20240405

Find record

Citation metrics

Archiving options